MD Anderson Research Highlights for January 10, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These adva
Source: newswise.com
Michael Andreeff News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Andreeff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Andreeff Today - Breaking & Trending Today
Andreeff Sheds Light on the Evaluation of the E-selectin Antagonist Uproleselan in AML
Dr Andreeff discusses the evaluation of uproleselan for the treatment of patients with acute myeloid leukemia, the rationale for targeting E-selectin in patients with this disease, how uproleselan could amplify the effects of chemotherapy in the treatment of these patients.
Source: onclive.com
Uproleselan Combinations Contribute to Robust Investigational Profile in AML
Michael Andreeff, MD, PhD, discusses the potential benefits of E-selectin inhibition in the AML tumor microenvironment, data that have contributed to the further development of uproleselan in this population, and additional AML targets under investigation that may broaden the treatment landscape.
Source: onclive.com
Drug Combination Restores Ability of Leading Treatment to Signal for Death of Blood Cancer Cells
/PRNewswire/ -- Despite the promise of new medications that promote cancer cell death in people with acute myeloid leukemia, leukemic cells often adopt...
Source: prnewswire.com
Mitophagy helps blood cancer cells to evade the killing effects of BH3 mimetic drug
Despite the promise of new medications that promote cancer cell death in people with acute myeloid leukemia, leukemic cells often adopt features that let them evade the drugs' effects within a year.
Source: news-medical.net